Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
IPO, Metsera
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S. IPO, aiming to capitalize on Wall Street's insatiable appetite for such treatments.
Metsera Seeks $289M Raise, $1.78B Valuation in IPO
The GLP-1 IPO arena has been heating up for the past two years and Metsera’s ask is one the largest in recent history.
Obesity drug developer Metsera sets terms for $275M IPO
Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has set terms for an upsized $275M initial public offering. In a recent SEC filing, Metsera (MTSR) said it was looking to offer 17.
Drug developer Maze Therapeutics eyes up to $728 million valuation in US IPO
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States.
4h
Venture Global’s IPO Flop Worsens as Shares Slump 20% From Debut
The fallout for Venture Global Inc., in the wake of a troubled initial public offering, accelerated amid a market selloff ...
6h
Daring Duo: After IPO These LNG Entrepreneurs Are Worth $20 Billion, Each
Even so the deal solidifies Venture Global’s place in the public markets with an impressive $50 billion market cap. And it ...
1h
on MSN
Rexpro Enterprises IPO allotment likely to be out today: Steps to check status, latest GMP
Rexpro Enterprises IPO shows a grey market premium of ₹10, indicating a potential listing price of ₹155. The IPO was ...
6h
on MSN
J&J-Backed Medtech Firm HistoSonics Considers US IPO
HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...
FierceBiotech
12h
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
2d
Venture Global IPO Signals A Return To Normal Order For LNG Exports
Venture Global's IPO represents a test for investor appetite for fossil fuel projects in the Trump administration.
2d
on MSN
Venture Global stock sinks on IPO day, indicating lack of investor interest in the LNG exporter
The stock market trading debut comes as incoming President Trump has said he plans to boost America’s energy production.
14h
Venture Global’s IPO stumble shows the limits of gassing up a valuation
More generally, markets have a way of recalibrating, and Venture Global’s IPO offers a nuanced lesson. It’s a reminder that valuations aren’t fixed by management or banker decree, but rather hammered ...
2h
Colform’s IPO oversubscribed
Steel products maker Colform Group Bhd’s initial public offering (IPO) of 30 million shares has been oversubscribed by 41.82 ...
12h
Doosan Unit Starts IPO in Prague With Eye on Nuclear Energy Plan
Czech steam-turbine manufacturer Doosan Skoda Power AS launched an initial public offering, touting an outlook for high ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback